Biomarker analyses from JAVELIN Renal 101: Avelumab + axitinib (A+Ax) versus sunitinib (S) in advanced renal cell carcinoma (aRCC).

出版年份 2019 全文链接

标题

作者

关键词

出版物

Volume 37, Issue 15_suppl, Pages 101-101

出版商

American Society of Clinical Oncology (ASCO)

发表日期

2019-05-27

DOI

10.1200/jco.2019.37.15_suppl.101

Explore over 38,000 international journals covering a vast array of academic fields.

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now